Top Banner
Co-morbidity among IDUs 1
58

Co-morbidity among IDUs

Jan 03, 2016

Download

Documents

hilel-spencer

Co-morbidity among IDUs. What is co-morbidity?. Presence of two or more conditions together in an individual (co-occurrence) The conditions can occur simultaneously One condition can precede another one. Co-morbidity among drug users. Physical illness HIV Hepatitis B & C Tuberculosis - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Co-morbidity among IDUs

Co-morbidity among IDUs

1

Page 2: Co-morbidity among IDUs

What is co-morbidity?Presence of two or more conditions

together in an individual (co-occurrence)

The conditions can occur simultaneously

One condition can precede another one

2

Page 3: Co-morbidity among IDUs

Co-morbidity among drug users

Physical illnessPhysical illnessHIVHepatitis B & CTuberculosisAbscessesRespiratory illnessSystemic

infections

Mental IllnessMental Illness Depression Anxiety disorders Psychosis Personality disorders

3

Page 4: Co-morbidity among IDUs

Why do co-morbidities occur?Drug use itself may lead to increased rates

Example: Smoking may lead to respiratory problems;

nicotine and alcohol may lead to cancer; injecting may lead to abscesses, HIV, Hepatitis B And C; living in poverty; homelessness due to drug use

Individual may use drugs due to existing physical/mental illnessExample:Person with pain condition may initiate drug use

and then become ‘addicted’ to the drugSome addictive drugs banned today were used

earlier to treat physical illness4 Contd…

Page 5: Co-morbidity among IDUs

Why do Co-morbidities occur?Both drug use and

other illness may be caused by overlapping factors leading to both illnessesExample:Genetic factors,

stress-related factorsDrug use and TB may

be caused by the individual living in poor socio-economic conditions

Common vulnerability factors

Drug usePhysical illness

5

Page 6: Co-morbidity among IDUs

Hepatitis

6

Page 7: Co-morbidity among IDUs

Hepatitis Hepatitis is inflammation of the liver

Liver can be inflamed by toxins, infection, alcohol, etc.

7

Page 8: Co-morbidity among IDUs

Viral Hepatitis

Type of

virus

Route of transmission

Prognosis

A Eating unhygienic food

Transient; very good prognosis

B Injection, sexual Chronic infection

C Injection, sexual Chronic infection

D Occurs along with Hepatitis B

Worsens prognosis of Hepatitis B

E Eating unhygienic food

Poorer than Hepatitis A

5 types of viral hepatitis: A, B, C, D, E

8

Page 9: Co-morbidity among IDUs

Hepatitis CHepatitis C is a

bloodborne infection caused by Hepatitis C virus

Hepatitis C infection is a major concern among IDUs80-90% IDUs infected

with Hepatitis C in some parts of India

9 Contd…

Page 10: Co-morbidity among IDUs

Hepatitis C Transmission of Hepatitis C

Sharing of contaminated injecting equipment in majority of cases Other injecting equipments such as spoons,

tourniquet, swabs, water in addition to N/S Contamination of hands during mixing of

drugTransfusion of infected blood and blood

productsSexual routeMother to baby (5% chance)Health-care workers are at risk for HCV

infection because of needle-stick accidents

10 Contd…

Page 11: Co-morbidity among IDUs

Hepatitis C Not transmitted by:

SneezingCoughingHuggingSharing eating utensils & drinking

glasses

11 Contd…

Page 12: Co-morbidity among IDUs

Hepatitis C Stages of infection

Acute: Some (20%) infected individuals have symptoms during this stage:

Fatigue, nausea, loss of appetite,

vomiting, jaundice

25% of individuals clear the virus from their body by 2 years of infection

12 Contd…

Page 13: Co-morbidity among IDUs

Hepatitis CChronic: 75% of infected individuals will

have chronic hepatitis with presence of virus in body and ability to transmit it to others

Symptoms include: Fluid retention that causes the swelling of belly and legs, jaundice, weight loss, mental disturbancesAbout 45% do not develop liver damageAbout 30-40% develop mild liver damageAbout 10-20% develop liver cirrhosisAbout 1-5% develop liver failure or liver

cancer13 Contd…

Page 14: Co-morbidity among IDUs

Hepatitis CPrevention of Hep C

Do not share needles or any drug paraphernalia

Do not share razors and toothbrushesPractice safe sex by use of condoms and

barriersHealth-care workers should use gloves

when dealing with bloodDo not donate blood if one has Hep C

14

Page 15: Co-morbidity among IDUs

Hepatitis C – ManagementEDUCATE every IDU on

The transmission dynamics of Hep C

Stress use of safe injecting equipment (not only N/S, but also others)

Teach the clients on safe injecting techniques

15 Contd…

Page 16: Co-morbidity among IDUs

Hepatitis C - Management

Instil hope in the patient that not every case is fatal

Take it easy; get plenty of restHealthy and well-balanced diet is essentialDO NOT DRINK ALCOHOL of any kindAvoid intake of fatty foodsAvoid medicines and substances that can

cause harm to liver (such as paracetamol for fever)

Avoid prolonged, vigorous exercise until symptoms start to improve

16 Contd…

Page 17: Co-morbidity among IDUs

Hepatitis C – ManagementIDU with Hep C symptoms should be

immediately referred to the hospital for further tests and treatment

A combination of Inj. Interferon and Tab. Ribavirin is the standard for treatment of Hep C

There is currently no vaccine for Hep C but patient should be vaccinated against Hepatitis A and Hepatitis B.

17

Page 18: Co-morbidity among IDUs

Hepatitis BHepatitis B: Caused by infection with HBVSymptoms:JaundiceExtreme tirednessMild feverHeadacheLoss of appetite, nausea and vomitingConstant pain on the right side of the

stomachDiarrhoea or constipationMuscle aches or joint painSkin rash18 Contd…

Page 19: Co-morbidity among IDUs

Hepatitis BTransmissionUnsafe sexual practicesSharing of needles and other equipment

such as cotton, cookers, tourniquet, straws, pipes, swabs, water

Health-care workers are at the risk for HBV infection because of needle-stick injuries

From mother to childSharing of needles used for body piercing

or tattooingSharing of razors and toothbrushes

19 Contd…

Page 20: Co-morbidity among IDUs

Diagnosis Through ELISA blood test

Management : It depends upon whether the infection is acute or chronic There is no specific treatment for acute

hepatitis B. But it is important to maintain comfort and adequate nutritional balance, including replacement of fluids that are lost from vomiting and diarrhoea

For Hepatitis B+ patients, fatty food, alcohol and high intake of salt is avoided

Chronic Hepatitis B+ can be treated with drugs, including interferon and antiviral agents 20

Hepatitis B

Contd…

Page 21: Co-morbidity among IDUs

Hepatitis B Prevention

Hepatitis B can be prevented by taking Hepatitis B vaccine. It is very effective and safe and is given in 3 doses. It can be given at any age

1st injection – at any given time2nd injection – after one month3rd injection – 6 months after the first

dose

21 Contd…

Page 22: Co-morbidity among IDUs

Hepatitis BOther ways to protect oneself

Practice safe sexDo not share needles while injecting drugsDo not share anything that might have

blood on it, such as razor, toothbrush, etc.Health workers should follow standard

precautions; handle the needles and sharps carefully

If pregnant, notify health practitioner in case of any of the risk factors for HBV infection

22

Page 23: Co-morbidity among IDUs

Tuberculosis

23

Page 24: Co-morbidity among IDUs

Tuberculosis (TB)Caused by a microscopic

organism – bacteria – mycobacterium tuberculosis

Can affect any body part Usually affects lungsOther sites: lymph

nodes, bone, brain, spinal cord, genital-urinary system, etc.

TB causing bacteria

24 Contd…

Page 25: Co-morbidity among IDUs

TuberculosisTB is contagious and spreads through air:

Transmitted from one person to another through droplets

When an infected person sneezes, coughs or talks, tiny droplets of saliva/mucus spread to another person, who can get infected

If not treated, each infected person with active TB will infect 10 – 15 people every year

TB is not transmitted by touching clothes or shaking hands of an infected person

25 Contd…

Page 26: Co-morbidity among IDUs

TuberculosisInhaled by

another person

Entry into his lungs

Strong immune system

Low immune system

Tuberculosis disease

Fibre wall around the bacteria

If low immunity

Bacteria breaks the wall

Droplets

spread

26 Contd…

Page 27: Co-morbidity among IDUs

Tuberculosis

Risk factors for contacting tuberculosis

IDUs Diabetes Certain cancers HIV infection Health-care workers,

including doctors and nurses

Living with a person who has active TB

Poverty Homelessness Nursing home residents Prison inmates Alcoholics

27

Page 28: Co-morbidity among IDUs

TuberculosisSymptoms of active tuberculosis

Coughing up of sputum Coughing blood Shortness of breath If other systems involved,

symptoms according to the function of the organ

Brain: Fits,

Unconsciousness

Generalised tiredness/weakness

Weight loss Fever Night sweats Cough Chest pain

28 Contd…

Page 29: Co-morbidity among IDUs

TuberculosisDiagnosis based on

Symptom profileChest X-raySputum examinationSkin test (Monteux test)

TreatmentNearest TB centre under RNTCP Directly Observed Treatment (DOT)Duration 9-12 months for complete curePerson becomes non-infectious within 3

weeks of initiating treatment 29 Contd…

Page 30: Co-morbidity among IDUs

TuberculosisOther important considerations

TB is the leading killer of people with HIV HIV infected people are 20-40 times

more likely to develop active TB

Multi-drug resistant TB (MDR-TB): Form of TB that is difficult to treat as it fails to respond to standard treatment. It is also expensive to treat

30 Contd…

Page 31: Co-morbidity among IDUs

TuberculosisIDU related issues for TB

IDUs have a very high rate of TB Reasons are many – poverty,

homelessness, poor living conditions, low immunity, poor nutrition, high HIV rates

Early symptoms of TB may be mistaken for other conditionsExampleWeight loss, weakness or tiredness

general debilityCough, chest pain chronic bronchitis

associated with co-morbid smoking 31 Contd…

Page 32: Co-morbidity among IDUs

TuberculosisDuring every follow-up, symptoms of TB

must be positively ruled outBaseline screening must be ensured by

referral to the physicianClients should be educated on

signs/symptoms of TBClients with symptoms resembling TB must

be referred to nearby DOT centreFor those on treatment for TB: Counselling

for adherence; physically verify whether the client is taking TB medicines or not

32

Page 33: Co-morbidity among IDUs

Mental Illness

33

Page 34: Co-morbidity among IDUs

There are various kinds of mental illness that can co-exist with drug dependence in an IDU

Example

DepressionAnxiety disordersPsychosis

Mental Illness

34

Page 35: Co-morbidity among IDUs

Mental Illness – Depression

Depression is morbid state of sadness

Affects the productivity and normal functioning of an individual

35

Page 36: Co-morbidity among IDUs

Depression – Symptoms Symptoms in an individual for at least two week duration

leading to difficulty in work OR personal suffering

Low mood /sadness Reduced energy Reduced interest in work and

pleasure Reduced concentration Disturbed sleep Loss of appetite Reduced self-esteem and

confidence

Feeling guilty for even small mistakes

Feeling hopeless and helpless

Suicidal acts/attempts

36

Page 37: Co-morbidity among IDUs

Mental Illness – Anxiety Disorders Anxiety is unreasonable fear, or fear which

is more than what is expected in the given situation

The fear is termed an illness if it: Occurs without any reason Is more than what is expected in the

given situation for a majority of individuals

Affects the individual’s work and social life

37 Contd…

Page 38: Co-morbidity among IDUs

Mental Illness – Anxiety Disorders – Symptoms Excessive unrealistic

worrying Trembling/shaking Churning stomach Nausea Diarrhoea Headache Backache Heart palpitations Sweating/flushing

Numbness/pins and needle sensation in arms, hands or legs

Restlessness Easily tired Poor concentration Easy irritability Muscle tension Frequent urination Sleep difficulties Easily startled

Apart from anxiety as the main symptom, one or more of the following exist/are:

38

Page 39: Co-morbidity among IDUs

Mental Illness – Anxiety Disorders – Types Examples of anxiety disorders:Phobias: (irrational fear of a specific object,

animal or situation, e.g. phobia for heights, spiders, water, exams)

Panic disorder: repeated panic attacks (state of extreme anxiety and fear with sense of dying without any reason)

Obsessive compulsive disorder:(for e.g., the individual may have repeated thoughts of being dirty/ unclean and repeatedly washes his hands)

39

Page 40: Co-morbidity among IDUs

Mental illness – Psychosis

Psychosis is characterised by a loss of reality, disorganisation in thoughts, perception and behaviour

Example● Schizophrenia● Acute psychosis

40

Page 41: Co-morbidity among IDUs

Psychosis – SymptomsDelusions: False beliefs of the person despite

evidence to contrary. Examples include: Belief of being attacked, Belief that one is very powerful, Belief that others are talking about one in bad manner

Hallucinations: Example A person may hear voices talking bad about

him/ swearing at him when in reality nobody is talking, and others around the person are not able to hear it

41

Page 42: Co-morbidity among IDUs

Mental Illness – Providing Services to the IDUIf the IDU presents with one of the symptoms

of mental illness, refer to the counsellor/doctor of the TI; refer to psychiatrist if available in the nearby hospital

42

Page 43: Co-morbidity among IDUs

Mental Illness – Counselling IssuesEducate the client that

Mental illnesses are treatable

Having a mental illness does not mean that the person has some defect of will power

Instill hope that outcome of mental illnesses such as depression and anxiety is good, if treated for adequate duration

43 Contd…

Page 44: Co-morbidity among IDUs

Mental Illness – Counselling IssuesReinforce risk reduction message, as the

chances of sharing are increased due to despair

Emphasize on chances of overdoseDue to suicidal ideationTo relieve symptoms of mental illness

Seek support of family during this crisis of the IDU

Regularly follow up with IDU and counsel him during the follow- up phase

44

Page 45: Co-morbidity among IDUs

Role of the PMEstablish, strengthen and maintain referral

and linkagesEducate clients on prevention Ensure adherence to treatment prescribed Conduct periodic training of the outreach

staff, nurse/counsellors on such co-morbid conditions

45

Page 46: Co-morbidity among IDUs

Antiretroviral Therapy

46

Page 47: Co-morbidity among IDUs

What is ART?ART stands for Antiretroviral Therapy

This is the main type of treatment for HIV or AIDS

 It is not a cure, but it can stop people from

becoming ill for many years  Thus, ART

Delays the progress of HIV Prolongs the person’s lifespan Improves the overall quality of life

47

Page 48: Co-morbidity among IDUs

ART for IDUsIDUs are often excluded from ART services

because of many misconceptions and also because of stigma they have to face

Service providers have a lot of misconceptions:They believe that IDUs are very poor at

adhering to ART drugsThey believe that IDUs need to be clean of

drugs to start ART!

48

Page 49: Co-morbidity among IDUs

Facts Worldwide studies have shown there is no

difference in adherence levels between IDUs and non-IDUs when it comes to ART!

Response to ART by IDUs is similar to response by non-IDUs

All IDUs who are medically eligible for ART should receive care and treatment as per the national guidelines

49

Page 50: Co-morbidity among IDUs

Starting ARTSteps to start ART

HIV positive IDUs

Refer to ART Centre: blood tests, CD4 cell

count, other infectionsCD4 cell count >

350/mm3

CD4 cell count < 350/mm3

6-monthly follow-up for repeating CD4 cell count

Initiate ART

Regular follow-up to ensure

ART adherence50

Page 51: Co-morbidity among IDUs

Issues Related to ARTAdherence

Opportunistic infection (OI)

Positive prevention

Care and support51

Page 52: Co-morbidity among IDUs

Adherence to ARTIt is very important that a person who is on

ART adheres to the treatment!

If a person discontinues taking the drugs it can lead to resistance, making it necessary to start on stronger drugs (2nd line ART) and limiting future treatment options

Counselling is important before starting on ART. Counsellors at the TI centres and at ICTC/ART centres are trained in counselling on ART

52

Page 53: Co-morbidity among IDUs

Opportunistic Infections (OIs)Clients with advanced HIV infection are vulnerable

to infections and malignancies that are called 'opportunistic infections' because of client’s weak immune system

TB, Pneumonia, malaria, drug reaction, acute diarrhoea, anaemia, etc. are some examples of OIs. Start ART after treating these conditions

If ART is started on time then incidence of OIs reduces

Clients coming to DIC with OIs should be referred to hospitals for further treatment

53

Page 54: Co-morbidity among IDUs

Positive PreventionPositive prevention aims to increase the

self-esteem, confidence and ability of HIV+ people to protect their own health and to avoid passing on the infection to others

Focus on preventive methods: Safer injecting and safer sex Safer behaviour helps to prevent

transmission of HIV to the partner Safer behaviour also helps in delaying

the progression of HIVHealthy and balanced diet is important

54

Page 55: Co-morbidity among IDUs

ConclusionProvided with adequate support and easy

accessibility, IDUs can adhere to ART and have similar outcomes to those of HIV patients not using drugs!

IDUs should be motivated for OST as it helps them adhere to ART regimens

55

Page 56: Co-morbidity among IDUs

ART – Role of PMEnsure

All the IDUs are tested for HIV through referral to ICTC

HIV+ IDUs are referred to ART centreAll HIV+ IDUs are registered at the ART

centreHIV positive IDUs eligible for treatment

are initiated on ARTClients on ART are regularly followed upThose with severe OIs are referred to CCCThose not eligible for ART get their CD4

cell count tested regularly56 Contd…

Page 57: Co-morbidity among IDUs

ART – Role of PMCreate referral mechanisms to facilitate

availability of above- mentioned services to IDU clients

Establish a mechanism to monitor the above-mentioned services

Advocacy with the health-care agencies to ensure availability of services

57

Page 58: Co-morbidity among IDUs

58